Yigeng Cao

7PUBLICATIONS
20CO-AUTHORS
Environmental epidemiologyHaematologyHaematological tumoursNanotoxicology, health and safetyPlanning and decision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2026
Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis.

|Jul 23, 2026
EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT.

|May 14, 2026
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML.

|Apr 24, 2026
Xenopax from a real-world and economic perspective: The future of second-line treatment and prophylaxis for SR-aGVHD.

|Sep 25, 2025
Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants.

Junren Chen, Yigeng Cao, Yahui Feng

|Jul 22, 2025
The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy.

Sisi Zhen, Li Liu, Futong Liu

Pageof 2

Frequent Collaborators

5 joint publications

Erlie Jiang

3 joint publications

Aiming Pang

3 joint publications

Donglin Yang

2 joint publications

Rongli Zhang